| 注册
首页|期刊导航|中国药物经济学|间断时间序列分析在我国卫生政策评估中的应用进展

间断时间序列分析在我国卫生政策评估中的应用进展

易洪彬 石丰豪 韩晟

中国药物经济学2024,Vol.19Issue(5):14-20,29,8.
中国药物经济学2024,Vol.19Issue(5):14-20,29,8.DOI:10.12010/j.issn.1673-5846.2024.05.002

间断时间序列分析在我国卫生政策评估中的应用进展

Advances in the Application of Interrupted Time Series Analysis in Health Policy Assessment in China

易洪彬 1石丰豪 1韩晟1

作者信息

  • 1. 北京大学医药管理国际研究中心,北京 100191
  • 折叠

摘要

Abstract

Objective To summarize the application progress and development trend of interrupted time series analysis in health policy assessment in China.Methods Relevant literatures in PubMed,Web of science and CNKI were retrieved respectively,and the method of systematic review was adapted for analysis.Besides,PRISMA criteria was followed to screen literatures in this study.Results A total of 89 literatures were included for research.After numerous analyses,we found that interrupted time series analysis was mainly used to assess new medical reform policies in China.And single-group interrupted time series analysis and segmented regression model were the main models being used in these researches.In addition,there was also the evidence showing that proportion of drugs and hospitalization expenses were the main outcome variables.Researchers often used Durbin-Watson test to detect the autocorrelation in their studies.Conclusion Interrupted time series analysis being used in studies shows a trend of the diversification of health policy,and it also shows that outcome variables are widely used in multi-type health policy assessment in China.However,some research designs still have deficiencies.

关键词

间断时间序列分析/卫生政策/政策评估/系统综述

Key words

Interrupted time series analysis/Health policy/Policy assessment/Systematic reviews

分类

医药卫生

引用本文复制引用

易洪彬,石丰豪,韩晟..间断时间序列分析在我国卫生政策评估中的应用进展[J].中国药物经济学,2024,19(5):14-20,29,8.

中国药物经济学

1673-5846

访问量0
|
下载量0
段落导航相关论文